<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35062313</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Antidepressant Sertraline Is a Broad-Spectrum Inhibitor of Enteroviruses Targeting Viral Entry through Neutralization of Endolysosomal Acidification.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">109</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14010109</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is an etiological agent of hand foot and mouth disease and can also cause neurological complications in young children. However, there are no approved drugs as of yet to treat EV71 infections. In this study, we conducted antiviral drug screening by using a Food and Drug Administration (FDA)-approved drug library. We identified five drugs that showed dose-dependent inhibition of viral replication. Sertraline was further characterized because it exhibited the most potent antiviral activity with the highest selectivity index among the five hits. The antiviral activity of sertraline was noted for other EV serotypes. The drug's antiviral effect is not likely associated with its approved indications as an antidepressant and its mode-of-action as a selective serotonin reuptake inhibitor. The time-of-addition assay revealed that sertraline inhibited an EV71 infection at the entry stage. We also showed that sertraline partitioned into acidic compartments, such as endolysosomes, to neutralize the low pH levels. In agreement with the findings, the antiviral effect of sertraline could be greatly relieved by exposing virus-infected cells to extracellular low-pH culture media. Ultimately, we have identified a use for an FDA-approved antidepressant in broad-spectrum EV inhibition by blocking viral entry through the alkalization of the endolysosomal route.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Kuan-Chi</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Bang-Yan</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Pin</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Cheng Kung University, Tainan 70101, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Wen-Wen</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Department of Clinical Pathology, Cheng Hsin General Hospital, Taipei 11220, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Cheng-Wen</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0003-0165-2652</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>Szu-Hao</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>QUC7NX6WMB</RegistryNumber><NameOfSubstance UI="D020280">Sertraline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020280" MajorTopicYN="N">Sertraline</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antidepressant sertraline</Keyword><Keyword MajorTopicYN="N">broad-spectrum antiviral</Keyword><Keyword MajorTopicYN="N">drug repurposing</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">host-cell targets</Keyword><Keyword MajorTopicYN="N">viral entry</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35062313</ArticleId><ArticleId IdType="pmc">PMC8780434</ArticleId><ArticleId IdType="doi">10.3390/v14010109</ArticleId><ArticleId IdType="pii">v14010109</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhoades R.E., Tabor-Godwin J.M., Tsueng G., Feuer R. Enterovirus infections of the central nervous system. Virology. 2011;411:288&#x2013;305. doi: 10.1016/j.virol.2010.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.12.014</ArticleId><ArticleId IdType="pmc">PMC3060663</ArticleId><ArticleId IdType="pubmed">21251690</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S.-L., Pan H., Liu P., Amer S., Chan T.-C., Zhan J., Huo X., Liu Y., Teng Z., Wang L., et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev. Med. Virol. 2015;25:115&#x2013;128. doi: 10.1002/rmv.1827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1827</ArticleId><ArticleId IdType="pubmed">25704797</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J., Van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Genet. 2018;16:368&#x2013;381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Lyoo H., van der Schaar H.M., Strating J., van Kuppeveld F.J. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections. Curr. Opin. Virol. 2017;24:1&#x2013;8. doi: 10.1016/j.coviro.2017.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.009</ArticleId><ArticleId IdType="pmc">PMC7172203</ArticleId><ArticleId IdType="pubmed">28411509</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.-Y., Shih S.-R. Cell and tissue tropism of enterovirus 71 and other enteroviruses infections. J. Biomed. Sci. 2014;21:18. doi: 10.1186/1423-0127-21-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-18</ArticleId><ArticleId IdType="pmc">PMC3995930</ArticleId><ArticleId IdType="pubmed">24602216</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Iizuka S., Yamashita T., Minagawa H., Mizuta K., Okamoto M., Nishimura H., Sanjoh K., Katsushima N., Itagaki T., et al. Human SCARB2-Dependent Infection by Coxsackievirus A7, A14, and A16 and Enterovirus 71. J. Virol. 2012;86:5686&#x2013;5696. doi: 10.1128/JVI.00020-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00020-12</ArticleId><ArticleId IdType="pmc">PMC3347270</ArticleId><ArticleId IdType="pubmed">22438546</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain K.M., Leong K.L.J., Ng M.M.-L., Chu J.J.H. The Essential Role of Clathrin-mediated Endocytosis in the Infectious Entry of Human Enterovirus 71. J. Biol. Chem. 2011;286:309&#x2013;321. doi: 10.1074/jbc.M110.168468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.-L., Liu Y.-G., Zhou Y.-T., Zhao P., Ren H., Xiao M., Zhu Y.-Z., Qi Z.-T. Endophilin-A2-mediated endocytic pathway is critical for enterovirus 71 entry into caco-2 cells. Emerg. Microbes Infect. 2019;8:773&#x2013;786. doi: 10.1080/22221751.2019.1618686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1618686</ArticleId><ArticleId IdType="pmc">PMC6542187</ArticleId><ArticleId IdType="pubmed">31132962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.-Y., Yang Y.-T., Yu S.-L., Hsiao K.-N., Liu C.-C., Sia C., Chow Y.-H. Caveolar Endocytosis Is Required for Human PSGL-1-Mediated Enterovirus 71 Infection. J. Virol. 2013;87:9064&#x2013;9076. doi: 10.1128/JVI.00573-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00573-13</ArticleId><ArticleId IdType="pmc">PMC3754029</ArticleId><ArticleId IdType="pubmed">23760234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.-W., Lin H.-Y., Tsou Y.-L., Chitra E., Hsiao K.-N., Shao H.-Y., Liu C.-C., Sia C., Chong P., Chow Y.-H. Human SCARB2-Mediated Entry and Endocytosis of EV71. PLoS ONE. 2012;7:e30507. doi: 10.1371/journal.pone.0030507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan M., Yan J., Xun J., Chen C., Zhang Y., Wang M., Chu W., Song Z., Hu Y., Zhang S., et al. Enhanced human enterovirus 71 infection by endocytosis inhibitors reveals multiple entry pathways by enterovirus causing hand-foot-and-mouth diseases. Virol. J. 2018;15:1&#x2013;13. doi: 10.1186/s12985-017-0913-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0913-3</ArticleId><ArticleId IdType="pmc">PMC5751926</ArticleId><ArticleId IdType="pubmed">29298696</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Linden L., Wolthers K.C., van Kuppeveld F.J. Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses. 2015;7:4529&#x2013;4562. doi: 10.3390/v7082832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y.-Y., Liu Y.-N., Wang W., Kao F.-J., Kung S.-H. In vivo dynamics of enterovirus protease revealed by fluorescence resonance emission transfer (FRET) based on a novel FRET pair. Biochem. Biophys. Res. Commun. 2007;353:939&#x2013;945. doi: 10.1016/j.bbrc.2006.12.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.12.145</ArticleId><ArticleId IdType="pubmed">17207462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W.-W., Kung F.-Y., Deng P.-A., Lin Y.-C., Lin C.-W., Kung S.-H. Development of a fluorescence resonance energy transfer&#x2013;based intracellular assay to identify novel enterovirus 71 antivirals. Arch. Virol. 2016;162:713&#x2013;720. doi: 10.1007/s00705-016-3143-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-3143-x</ArticleId><ArticleId IdType="pubmed">27873071</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriani A., Furukawa T.A., Salanti G., Chaimani A., Atkinson L.Z., Ogawa Y., Leucht S., Ruhe H.G., Turner E.H., Higgins J.P.T., et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet. 2018;391:1357&#x2013;1366. doi: 10.1016/S0140-6736(17)32802-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)32802-7</ArticleId><ArticleId IdType="pmc">PMC5889788</ArticleId><ArticleId IdType="pubmed">29477251</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman J.A., Gouaux E. Structural basis for recognition of diverse antidepressants by the human serotonin transporter. Nat. Struct. Mol. Biol. 2018;25:170&#x2013;175. doi: 10.1038/s41594-018-0026-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0026-8</ArticleId><ArticleId IdType="pmc">PMC5962350</ArticleId><ArticleId IdType="pubmed">29379174</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou H.-Y., Lu W.-W., Wu K.-Y., Lin C.-W., Kung S.-H. Idarubicin is a broad-spectrum enterovirus replication inhibitor that selectively targets the virus internal ribosomal entry site. J. Gen. Virol. 2016;97:1122&#x2013;1133. doi: 10.1099/jgv.0.000431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000431</ArticleId><ArticleId IdType="pubmed">26879094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai M.-T., Cheng Y.-H., Liu Y.-N., Liao N.-C., Lu W.-W., Kung S.-H. Real-Time Monitoring of Human Enterovirus (HEV)-Infected Cells and Anti-HEV 3C Protease Potency by Fluorescence Resonance Energy Transfer. Antimicrob. Agents Chemother. 2009;53:748&#x2013;755. doi: 10.1128/AAC.00841-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00841-08</ArticleId><ArticleId IdType="pmc">PMC2630644</ArticleId><ArticleId IdType="pubmed">19015331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H., Kim C., Kim D.-E., Song J.-H., Choi M., Choi K., Kang M., Lee K., Kim H.S., Shin J.S., et al. Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses. Antivir. Res. 2015;124:1&#x2013;10. doi: 10.1016/j.antiviral.2015.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.10.011</ArticleId><ArticleId IdType="pubmed">26526589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W.-W., Hsu Y.-Y., Yang J.-Y., Kung S.-H. Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem. Biophys. Res. Commun. 2004;325:494&#x2013;499. doi: 10.1016/j.bbrc.2004.10.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.10.062</ArticleId><ArticleId IdType="pubmed">15530419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rujkijyanont P., Adams S.-L., Beyene J., Dror Y. Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br. J. Haematol. 2009;145:806&#x2013;815. doi: 10.1111/j.1365-2141.2009.07692.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2009.07692.x</ArticleId><ArticleId IdType="pubmed">19438500</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadanaciva S., Lu S., Gebhard D.F., Jessen B.A., Pennie W.D., Will Y. A high content screening assay for identifying lysosomotropic compounds. Toxicol. Vitr. 2011;25:715&#x2013;723. doi: 10.1016/j.tiv.2010.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2010.12.010</ArticleId><ArticleId IdType="pubmed">21184822</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S., Huang L., Shen R., Bernard-Cacciarella M., Zhou P., Hu C., Di Benedetto M., Janin A., Bousquet G., Li H., et al. Drug resistance-related sunitinib sequestration in autophagolysosomes of endothelial cells. Int. J. Oncol. 2019;56:113&#x2013;122. doi: 10.3892/ijo.2019.4924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2019.4924</ArticleId><ArticleId IdType="pmc">PMC6910192</ArticleId><ArticleId IdType="pubmed">31789391</ArticleId></ArticleIdList></Reference><Reference><Citation>Madshus I.H., Olsnes S., Sandvig K. Mechanism of entry into the cytosol of poliovirus type 1: Requirement for low pH. J. Cell Biol. 1984;98:1194&#x2013;1200. doi: 10.1083/jcb.98.4.1194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.98.4.1194</ArticleId><ArticleId IdType="pmc">PMC2113218</ArticleId><ArticleId IdType="pubmed">6325467</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D., Patel A., Nolan W.C., Zhang Y., Holtzman M.J. High Throughput Screening for Small Molecule Enhancers of the Interferon Signaling Pathway to Drive Next-Generation Antiviral Drug Discovery. PLoS ONE. 2012;7:e36594. doi: 10.1371/journal.pone.0036594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036594</ArticleId><ArticleId IdType="pmc">PMC3344904</ArticleId><ArticleId IdType="pubmed">22574190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun J., Kihara Y., Jonnalagadda D., Blaho V.A. Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders. Annu. Rev. Pharmacol. Toxicol. 2019;59:149&#x2013;170. doi: 10.1146/annurev-pharmtox-010818-021358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010818-021358</ArticleId><ArticleId IdType="pmc">PMC6392001</ArticleId><ArticleId IdType="pubmed">30625282</ArticleId></ArticleIdList></Reference><Reference><Citation>Olawi N., Kr&#xfc;ger M., Grimm D., Infanger M., Wehland M. Nebivolol in the treatment of arterial hypertension. Basic Clin. Pharmacol. Toxicol. 2019;125:189&#x2013;201. doi: 10.1111/bcpt.13248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.13248</ArticleId><ArticleId IdType="pubmed">31066991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio P.A. Septisol antiseptic foam: A sensible alternative to the conventional surgical scrub. Int. Surg. 1987;72:243&#x2013;246. doi: 10.1016/S0022-5347(17)40708-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5347(17)40708-7</ArticleId><ArticleId IdType="pubmed">3448039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong W., Bai X.-C., Sleebs B.E., Triglia T., Brown A., Thompson J.K., Jackson K.E., Hanssen E., Marapana D.S., Fernandez I.S., et al. Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis. Nat. Microbiol. 2017;2:1&#x2013;9. doi: 10.1038/nmicrobiol.2017.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2017.31</ArticleId><ArticleId IdType="pmc">PMC5439513</ArticleId><ArticleId IdType="pubmed">28288098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Leung C., Tahan S., Wang D. Entry by multiple picornaviruses is dependent on a pathway that includes TNK2, WASL, and NCK1. eLife. 2019;8:e50276. doi: 10.7554/eLife.50276.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.50276</ArticleId><ArticleId IdType="pmc">PMC6904212</ArticleId><ArticleId IdType="pubmed">31769754</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F., Zhao X., Hu S., Li J., Yin L., Mei S., Liu T., Wang Y., Ren L., Cen S., et al. Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry. Sci. Rep. 2016;6:33150. doi: 10.1038/srep33150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33150</ArticleId><ArticleId IdType="pmc">PMC5016833</ArticleId><ArticleId IdType="pubmed">27608771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmi F., Hensley T., Pope C., Funk R.S., Loewen G.J., Buckley D.B., Parkinson A. Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells) Drug Metab. Dispos. 2013;41:897&#x2013;905. doi: 10.1124/dmd.112.050054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/dmd.112.050054</ArticleId><ArticleId IdType="pmc">PMC3608459</ArticleId><ArticleId IdType="pubmed">23378628</ArticleId></ArticleIdList></Reference><Reference><Citation>Norinder U., Tuck A., Norgren K., Kos V.M. Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19. Biomed. Pharmacother. 2020;130:110582. doi: 10.1016/j.biopha.2020.110582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110582</ArticleId><ArticleId IdType="pmc">PMC7392152</ArticleId><ArticleId IdType="pubmed">32763818</ArticleId></ArticleIdList></Reference><Reference><Citation>Salata C., Calistri A., Parolin C., Baritussio A., Pal&#xf9; G. Antiviral activity of cationic amphiphilic drugs. Expert Rev. Anti-infective Ther. 2017;15:483&#x2013;492. doi: 10.1080/14787210.2017.1305888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2017.1305888</ArticleId><ArticleId IdType="pmc">PMC7103695</ArticleId><ArticleId IdType="pubmed">28286997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.W., Yam W.K., Sun J., Chu J.J.H. An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease. Antivir. Res. 2018;149:143&#x2013;149. doi: 10.1016/j.antiviral.2017.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.11.017</ArticleId><ArticleId IdType="pubmed">29175128</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch C., Dyall J., Xu S., Nelson E., Postnikova E., Liang J., Zhou H., DeWald L., Thomas C., Wang A., et al. Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo. Microorganisms. 2021;9:566. doi: 10.3390/microorganisms9030566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9030566</ArticleId><ArticleId IdType="pmc">PMC7998926</ArticleId><ArticleId IdType="pubmed">33801811</ArticleId></ArticleIdList></Reference><Reference><Citation>Madrid P.B., Panchal R., Warren T.K., Shurtleff A.C., Endsley A.N., Green C.E., Kolokoltsov A., Davey R., Manger I.D., Gilfillan L., et al. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infect. Dis. 2015;1:317&#x2013;326. doi: 10.1021/acsinfecdis.5b00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.5b00030</ArticleId><ArticleId IdType="pubmed">27622822</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpinteiro A., Edwards M.J., Hoffmann M., Kochs G., Gripp B., Weigang S., Adams C., Carpinteiro E., Gulbins A., Keitsch S., et al. Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells. Cell Rep. Med. 2020;1:100142. doi: 10.1016/j.xcrm.2020.100142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100142</ArticleId><ArticleId IdType="pmc">PMC7598530</ArticleId><ArticleId IdType="pubmed">33163980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornhuber J., Tripal P., Reichel M., Terfloth L., Bleich S., Wiltfang J., Gulbins E. Identification of New Functional Inhibitors of Acid Sphingomyelinase Using a Structure&#x2212;Property&#x2212;Activity Relation Model. J. Med. Chem. 2008;51:219&#x2013;237. doi: 10.1021/jm070524a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm070524a</ArticleId><ArticleId IdType="pubmed">18027916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N., S&#xe1;nchez-Rico M., Cougoule C., Gulbins E., Kornhuber J., Carpinteiro A., Becker K.A., Reiersen A.M., Lenze E.J., Seftel D., et al. Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: Current evidence and potential mechanisms. Mol. Psychiatry. 2021:1&#x2013;2. doi: 10.1038/s41380-021-01254-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01254-3</ArticleId><ArticleId IdType="pmc">PMC8359627</ArticleId><ArticleId IdType="pubmed">34385600</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller M.E., Adhikary S., Kolokoltsov A.A., Davey R.A. Ebolavirus Requires Acid Sphingomyelinase Activity and Plasma Membrane Sphingomyelin for Infection. J. Virol. 2012;86:7473&#x2013;7483. doi: 10.1128/JVI.00136-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00136-12</ArticleId><ArticleId IdType="pmc">PMC3416309</ArticleId><ArticleId IdType="pubmed">22573858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Zhao Y., Fry E.E., Stuart D.I. Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection. J. Med. Chem. 2018;61:724&#x2013;733. doi: 10.1021/acs.jmedchem.7b01249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.7b01249</ArticleId><ArticleId IdType="pmc">PMC5808380</ArticleId><ArticleId IdType="pubmed">29272110</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano K., Kimura R., Sugimoto Y., Yamada J., Uchida S., Kato Y., Hashimoto H., Yamada S. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br. J. Pharmacol. 2005;144:695&#x2013;702. doi: 10.1038/sj.bjp.0706108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706108</ArticleId><ArticleId IdType="pmc">PMC1576050</ArticleId><ArticleId IdType="pubmed">15678084</ArticleId></ArticleIdList></Reference><Reference><Citation>Regenthal R., Krueger M., Koeppel C., Preiss R. Drug Levels: Therapeutic and Toxic Serum/Plasma Concentrations of Common Drugs. Int. J. Clin. Monit. Comput. 1999;15:529&#x2013;544. doi: 10.1023/A:1009935116877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1009935116877</ArticleId><ArticleId IdType="pubmed">12578052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis R.J., Angier M.K., Williamson K.S., Johnson R.D. Analysis of Sertraline in Postmortem Fluids and Tissues in 11 Aviation Accident Victims. J. Anal. Toxicol. 2013;37:208&#x2013;216. doi: 10.1093/jat/bkt014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jat/bkt014</ArticleId><ArticleId IdType="pubmed">23511306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedahl M., Johansen S.S., Linnet K. Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline. J. Anal. Toxicol. 2017;42:149&#x2013;156. doi: 10.1093/jat/bkx098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jat/bkx098</ArticleId><ArticleId IdType="pubmed">29244076</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercorelli B., Pal&#xf9; G., Loregian A. Drug Repurposing for Viral Infectious Diseases: How Far Are We? Trends Microbiol. 2018;26:865&#x2013;876. doi: 10.1016/j.tim.2018.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2018.04.004</ArticleId><ArticleId IdType="pmc">PMC7126639</ArticleId><ArticleId IdType="pubmed">29759926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W., Sanderson P.E., Zheng W. Drug combination therapy increases successful drug repositioning. Drug Discov. Today. 2016;21:1189&#x2013;1195. doi: 10.1016/j.drudis.2016.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2016.05.015</ArticleId><ArticleId IdType="pmc">PMC4907866</ArticleId><ArticleId IdType="pubmed">27240777</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurgeit A., McDowell R., Moese S., Meldrum E., Schwendener R., Greber U.F. Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects. PLoS Pathog. 2012;8:e1002976. doi: 10.1371/journal.ppat.1002976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002976</ArticleId><ArticleId IdType="pmc">PMC3486884</ArticleId><ArticleId IdType="pubmed">23133371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Qin P., Huang Y.W. Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2. Cell Calcium. 2021;94:102360. doi: 10.1016/j.ceca.2021.102360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2021.102360</ArticleId><ArticleId IdType="pmc">PMC7825922</ArticleId><ArticleId IdType="pubmed">33516131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai Y., Kolokoltsov A.A., Chen C.-C., Tidwell M.W., Bauta W.E., Klugbauer N., Grimm C., Wahl-Schott C., Biel M., Davey R.A. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015;347:995&#x2013;998. doi: 10.1126/science.1258758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258758</ArticleId><ArticleId IdType="pmc">PMC4550587</ArticleId><ArticleId IdType="pubmed">25722412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinkenberger N., Schoggins J.W. Mucolipin-2 Cation Channel Increases Trafficking Efficiency of Endocytosed Viruses. mBio. 2018;9:e02314-17. doi: 10.1128/mBio.02314-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02314-17</ArticleId><ArticleId IdType="pmc">PMC5790917</ArticleId><ArticleId IdType="pubmed">29382735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunaratne G.S., Yang Y., Li F., Walseth T.F., Marchant J.S. NAADP-dependent Ca2+ signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system. Cell Calcium. 2018;75:30&#x2013;41. doi: 10.1016/j.ceca.2018.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2018.08.003</ArticleId><ArticleId IdType="pmc">PMC6251489</ArticleId><ArticleId IdType="pubmed">30121440</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>